Status:
COMPLETED
Minimally Invasive Surgical Approaches In Total Knee Arthroplasty
Lead Sponsor:
Mayo Clinic
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
The hypothesis of the proposed study is that performing total knee arthroplasty through a mini subvastus approach results in statistically significant differences in one or more of the above functiona...
Detailed Description
In order to assign patients to specific treatment groups in an unbiased manner, randomization will occur prior to surgery. The assigned treatment codes for patients in each group will be generated by ...
Eligibility Criteria
Inclusion
- Primary arthroplasty
- Age between 45 and 75 years old
- Single condylar implant design
Exclusion
- Revision arthroplasty
- Age less than 45 and greater than 75 years old
- Pre-operative flexion lower than 90 degrees
- Valgus or varus knee deformity greater than 15 degrees.
- The presence of infections, highly communicable diseases (AIDS, active tuberculosis, venereal disease, hepatitis) or metastasis disease.
- Significant neurological or musculoskeletal disorders or disease that may interfere with normal gait or weight bearing.
- Any congenital, developmental, or other bone disease or previous hip surgery that may, in the surgeon's judgment, interfere with TK prosthesis survival or success.
- Presence of previous prosthetic knee or hip replacement device.
- BMI \> 30.
- Pregnant women.
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01461356
Start Date
March 1 2007
End Date
September 1 2011
Last Update
October 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905